Results 191 to 200 of about 9,376,530 (330)
Alexithymic Characteristics in Children With Refractory Hematological Diseases
Isao Fukunishi, Toshihisa Tsuruta
openalex +1 more source
Binding of Doxorubicin to ALYREF disrupts its phase‐separated condensate and induces DNA damage and apoptosis in cardiomyocytes Abstract The clinical utility of the anticancer agent doxorubicin (DOX) is limited by its dose‐dependent cardiotoxicity.
Xinlu Gao +20 more
wiley +1 more source
Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition). [PDF]
Zhao B +28 more
europepmc +1 more source
BCOR gene alterations in hematologic diseases.
Sportoletti P, Sorcini D, Falini B.
europepmc +1 more source
This study discovered that the protein TEAD1a is crucial for neutrophil development. In zebrafish models, disrupting TEAD1a or its interaction with partner protein YAP1 caused severe neutrophil deficiency. TEAD1a functions during the early HSC stage, activates Notch1 signaling in the GMP stage, and triggers Spi1 and Cebpα to drive neutrophil terminal ...
Wang Yiqin +7 more
wiley +1 more source
CEBPA bZIP in-frame mutations in acute myeloid leukemia: prognostic and therapeutic implications
Fenghong Zhang +8 more
doaj +1 more source
Computed tomography findings of pneumonia resistant to empirical therapy in patients with hematologic diseases. [PDF]
Giuliani L +8 more
europepmc +1 more source
Laparoscopic Appendectomy for Acute Appendicitis Complicated by Pancytopenia in Two Patients with Hematologic Diseases. [PDF]
Kojima K +5 more
europepmc +1 more source
From Bench to Bedside: Emerging Paradigms in CAR‐T Cell Therapy for Solid Malignancies
This review discusses emerging paradigms in CAR‐T cell therapy for solid tumors, emphasizing strategies to overcome therapeutic barriers through synthetic biology, immune engineering, and combinatorial approaches. It highlights advancements in logic gating, modulation of the immune microenvironment, and innovative cell designs, providing valuable ...
Yang Chen +7 more
wiley +1 more source

